Jing-Houng Wang

发表

Clinical Significance of Hepatitis B Virus (HBV) Genotypes and Precore and Core Promoter Mutations Affecting HBV e Antigen Expression in Taiwan

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2005, Journal of Clinical Microbiology.

FibroScan and ultrasonography in the prediction of hepatic fibrosis in patients with chronic viral hepatitis

Sheng-Nan Lu, Chao-Hung Hung, Hock-Liew Eng, 2009, Journal of Gastroenterology.

Nivolumab Versus Regorafenib in Patients With Hepatocellular Carcinoma After Sorafenib Failure

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2021, Frontiers in Oncology.

Ultrasound is highly specific in diagnosing compensated cirrhosis in chronic hepatitis C patients in real world clinical practice

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2019, Medicine.

Revisiting the accuracy of splenomegaly by sonography in patients with chronic hepatitis B

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2020, Advances in Digestive Medicine.

Low accuracy of the national reporting system of acute hepatitis C infection in Taiwan, 1995–2004

Sheng-Nan Lu, Jing-Houng Wang, Chao-Hung Hung, 2010, Journal of gastroenterology and hepatology.

Chronic hepatitis B exhibited higher rate of hepatocellular carcinoma occurrence than hepatitis C in cirrhotic patients after effective antiviral treatment.

Chien-Hung Chen, Y. Chiu, Jing-Houng Wang, 2020, Journal of the Formosan Medical Association = Taiwan yi zhi.

A higher than expected recovery rate from hepatitis C infection amongst adolescents: a community study in a hepatitis C-endemic township in Taiwan.

Sheng-Nan Lu, Chuan‐Mo Lee, Jing-Houng Wang, 2004, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Viral Etiology of Hepatocellular Carcinoma and HCV Genotypes in Taiwan

Sheng-Nan Lu, Chao-Long Chen, C. Changchien, 2005, Intervirology.

Thyroid dysfunction in patients with chronic hepatitis C receiving a combined therapy of interferon and ribavirin: Incidence, associated factors and prognosis

Sheng-Nan Lu, Pei-Wen Wang, C. Changchien, 2006, Journal of gastroenterology and hepatology.

Dynamic α-fetoprotein, platelets and AST-to-platelet ratio index predict hepatocellular carcinoma in chronic hepatitis C patients with sustained virological response after antiviral therapy.

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2016, The Journal of antimicrobial chemotherapy.

Is Hepatitis C Virus Core Antigen an Adequate Marker for Community Screening?

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2012, Journal of Clinical Microbiology.

Comparison of prevalence for paraumbilical vein patency in patients with viral and alcoholic liver cirrhosis

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2002, American Journal of Gastroenterology.

Comparison of prevalence for paraumbilical vein patency in patients with viral and alcoholic liver cirrhosis

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2002 .

Associations of HBV Genotype B vs C Infection With Relapse After Cessation of Entecavir or Tenofovir therapy.

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Comparison of HBsAg changes between HBeAg-negative patients who discontinued or maintained entecavir therapy

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2019, Hepatology International.

Hepatitis B virus relapse rates in chronic hepatitis B patients who discontinue either entecavir or tenofovir

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2018, Alimentary pharmacology & therapeutics.

Antiviral effect of entecavir in nucleos(t)ide analogue‐naïve and nucleos(t)ide analogue‐experienced chronic hepatitis B patients without virological response at week 24 or 48 of therapy

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2014, Journal of viral hepatitis.

High Risk of Hepatitis B Virus Reactivation in Nucleos(t)ide Analogue-Induced Hepatitis B e Antigen Seroconverters Older Than 40 Years

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2014, Digestive Diseases and Sciences.

Virological response to entecavir reduces the risk of liver disease progression in nucleos(t)ide analogue-experienced HBV-infected patients with prior resistant mutants.

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2013, The Journal of antimicrobial chemotherapy.

A comparison of 4-year entecavir efficacy in nucleos(t)ide analog-naïve and -experienced adult Taiwanese chronic hepatitis B patients

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2013, Hepatology International.

Treatment Response and Evolution of HBV Resistance during Lamivudine plus Adefovir or Entecavir Therapy in Patients with Adefovir-Resistant Mutants

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2012, Antiviral therapy.

Hepatitis B virus genotype B results in better immediate, late and sustained responses to peginterferon‐alfa in hepatitis‐B‐e‐antigen‐positive patients

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2011, Journal of gastroenterology and hepatology.

Extended lamivudine consolidation therapy in hepatitis B e antigen-positive chronic hepatitis B patients improves sustained hepatitis B e antigen seroconversion

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2010, Scandinavian journal of gastroenterology.

A study on sequence variations in pre‐S/surface, X and enhancer II/core promoter/precore regions of occult hepatitis B virus in non‐B, non‐C hepatocellular carcinoma patients in Taiwan

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2009, International journal of cancer.

The role of HBV genotype, core promoter and precore mutations in advanced liver disease in renal transplant recipients.

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2009, Journal of hepatology.

Combined mutations in pre-s/surface and core promoter/precore regions of hepatitis B virus increase the risk of hepatocellular carcinoma: a case-control study.

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2008, The Journal of infectious diseases.

Combined Mutations in PreS / Surface and Core Promoter / Precore Regions of Hepatitis B Virus Increase the Risk of Hepatocellular Carcinoma : A Case-Control Study

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2008 .

Optimal treatment increased survival of hepatocellular carcinoma patients detected with community‐based screening

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2010, Journal of gastroenterology and hepatology.

Diabetes is associated with advanced fibrosis and fibrosis progression in non-genotype 3 chronic hepatitis C patients.

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2019, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Validation of clinical AJCC/UICC TNM staging system for hepatocellular carcinoma: Analysis of 5,613 cases from a medical center in southern Taiwan

Sheng-Nan Lu, Chao-Long Chen, Chi-Chih Wang, 2007, International journal of cancer.

Long-term efficacy of plasma-derived and recombinant hepatitis B vaccines in a rural township of Central Taiwan.

Sheng-Nan Lu, Chuan‐Mo Lee, Jing-Houng Wang, 2009, Vaccine.

Correlation Between Fatty Liver and Lipidemia in Taiwanese

C. Changchien, T. Tsai, Jing-Houng Wang, 2003 .

Contrast-enhanced Ultrasonography in Small Liver Tumors (< 3 cm)

C. Changchien, Jing-Houng Wang, 2008 .

Impact of diabetes mellitus on incidence of hepatocellular carcinoma in chronic hepatitis C patients treated with interferon‐based antiviral therapy

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2011, International journal of cancer.

Hepatitis C virus genotypes in southern Taiwan: prevalence and clinical implications.

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2006, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Clinical characteristics and prognosis of HCC occurrence after antiviral therapy for HCV patients between sustained and non-sustained responders.

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2019, Journal of the Formosan Medical Association = Taiwan yi zhi.

Incidence of needle tract seeding and responses of soft tissue metastasis by hepatocellular carcinoma postradiotherapy

Sheng-Nan Lu, C. Changchien, Chuan‐Mo Lee, 2007, Liver international : official journal of the International Association for the Study of the Liver.

Association of inflammatory and anti‐inflammatory cytokines with insulin resistance in chronic hepatitis C

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2009, Liver international : official journal of the International Association for the Study of the Liver.

Evolution of renal function under direct‐acting antivirals treatment for chronic hepatitis C: A real‐world experience

Sheng-Nan Lu, I. Sheen, R. Chien, 2019, Journal of viral hepatitis.

Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early/early stage hepatocellular carcinoma.

Sheng-Nan Lu, Chi-Chih Wang, Jing-Houng Wang, 2012, Journal of hepatology.

Association of vitamin D receptor gene polymorphisms with response to peginterferon plus ribavirin in Asian patients with chronic hepatitis C.

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2016, Journal of the Formosan Medical Association = Taiwan yi zhi.

Diagnostic sensitivity of hepatocellular carcinoma imaging and its application to non‐cirrhotic patients

Chi-Chih Wang, Yu-Fan Cheng, Chuan‐Mo Lee, 2011, Journal of gastroenterology and hepatology.

The association between steatosis and diabetes with hepatocellular carcinoma in non‐genotype 3 chronic hepatitis C patients

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2018, Liver international : official journal of the International Association for the Study of the Liver.

Association between PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma in Asian chronic hepatitis C patients: A longitudinal study.

Sheng-Nan Lu, Chien-Hung Chen, Chao-Min Huang, 2017, Journal of the Formosan Medical Association = Taiwan yi zhi.

Serum proteome predicts virological response in chronic hepatitis C genotype 1b patients treated with pegylated interferon plus ribavirin.

Sheng-Nan Lu, Chuan‐Mo Lee, Jing-Houng Wang, 2015, Journal of the Formosan Medical Association = Taiwan yi zhi.

Sorafenib use in hepatitis B virus‐ or hepatitis C virus‐related hepatocellular carcinoma: A propensity score matching study

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2021, The Kaohsiung journal of medical sciences.

Molecular epidemiological and clinical aspects of hepatitis D virus in a unique triple hepatitis viruses (B, C, D) endemic community in Taiwan

Sheng-Nan Lu, Chuan‐Mo Lee, Jing-Houng Wang, 2003, Journal of medical virology.

Predicting the prevalence of antibody to hepatitis C virus (HCV) in a community by the prevalence of elevated levels of alanine aminotransferase: a method to identify areas endemic for HCV.

Sheng-Nan Lu, Chuan‐Mo Lee, Jing-Houng Wang, 2002, The American journal of tropical medicine and hygiene.

Five‐year comparative risk of hepatocellular carcinoma development under entecavir or tenofovir treatment‐naïve patients with chronic hepatitis B‐related compensated cirrhosis in Taiwan

Sheng-Nan Lu, Chien-Hung Chen, R. Chien, 2020, Alimentary pharmacology & therapeutics.

Serial changes of clinical parameters in a patient with advanced hepatocellular carcinoma with portal vein thrombosis achieving complete response after treatment with sorafenib

Sheng-Nan Lu, Jing-Houng Wang, Chao-Hung Hung, 2014, OncoTargets and therapy.

Association between chronic viral hepatitis and metabolic syndrome in southern Taiwan: a large population‐based study

Sheng-Nan Lu, Jing-Houng Wang, C. Hsiao, 2018, Alimentary pharmacology & therapeutics.

Role of Viral Genotypes and Hepatitis B Viral Mutants in the Risk of Hepatocellular Carcinoma Associated with Hepatitis B and C Dual Infection

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2013, Intervirology.

Long term survival in patients with hepatocellular carcinoma directly invading the gastrointestinal tract: case reports and literature review.

S. Iyer, Chi-Chih Wang, Jing-Houng Wang, 2011, Surgical oncology.

Prognosis after resection of single large hepatocellular carcinoma: Results from an Asian high-volume liver surgery center

Chi-Chih Wang, Yueh-Wei Liu, C. Yong, 2020, PloS one.

A novel evidence of serial changes of bone mineral density in chronic hepatitis B patients treated with entecavir

Chien-Hung Chen, S. Chiu, Jing-Houng Wang, 2021, Hepatology International.

A scoring system to predict HBsAg seroclearance in hepatitis B and C coinfected patients treated with interferon and ribavirin in an Asian cohort

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2018, Medicine.

Relationship Between Flash Echo Gray Scale Imaging Features and Pathologic Findings in Hepatic Adenoma

Sheng-Nan Lu, Jing-Houng Wang, Chao-Hung Hung, 2002, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

The Influential Roles of Antibiotics Prophylaxis in Cirrhotic Patients with Peptic Ulcer Bleeding after Initial Endoscopic Treatments

Sheng-Nan Lu, Keng-Liang Wu, S. Chuah, 2014, PloS one.

The Outcome of Prophylactic Intravenous Cefazolin and Ceftriaxone in Cirrhotic Patients at Different Clinical Stages of Disease after Endoscopic Interventions for Acute Variceal Hemorrhage

Sheng-Nan Lu, Keng-Liang Wu, S. Chuah, 2013, PloS one.

The effects of cefazolin on cirrhotic patients with acute variceal hemorrhage after endoscopic interventions

Sheng-Nan Lu, Keng-Liang Wu, C. Changchien, 2011, Surgical Endoscopy.

Contrast-enhanced ultrasonographic spoke-wheel sign in hepatic focal nodular hyperplasia.

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2006, European journal of radiology.

Screening with Ultrasonography of Patients at High-Risk for Hepatocellular Carcinoma: Thrombocytopenia as a Valid Surrogate of Cirrhosis

Sheng-Nan Lu, Jing-Houng Wang, K. Kee, 2009 .

A polymorphism in interferon L3 is an independent risk factor for development of hepatocellular carcinoma after treatment of hepatitis C virus infection.

Sheng-Nan Lu, Hsiu-Hsi Chen, Chien-Hung Chen, 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Baseline and serial liver stiffness measurement in prediction of portal hypertension progression for patients with compensated cirrhosis

Sheng-Nan Lu, S. Chuah, Jing-Houng Wang, 2014, Liver international : official journal of the International Association for the Study of the Liver.

Liver stiffness measurement in cirrhotic patient — Implications of disease activity and treatment efficacy

Sheng-Nan Lu, Jing-Houng Wang, Chao-Hung Hung, 2012, The Kaohsiung journal of medical sciences.

Usefulness of Controlled Attenuation Parameter in Detecting and Monitoring Hepatic Steatosis with MRI-PDFF as Reference

Sheng-Nan Lu, Chien-Hung Chen, H. Ou, 2019, Digestive Diseases and Sciences.

Correlation of quantitative assay of hepatitis B surface antigen and HBV DNA levels in asymptomatic hepatitis B virus carriers

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2004, European journal of gastroenterology & hepatology.

Transient elastography and simple blood markers in the diagnosis of esophageal varices for compensated patients with hepatitis B virus‐related cirrhosis

Sheng-Nan Lu, Chien-Hung Chen, S. Chuah, 2012, Journal of gastroenterology and hepatology.

Improvement of Thrombocytopenia in Hepatitis C-Related Advanced Fibrosis Patients After Sustained Virological Response

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2013, Digestive Diseases and Sciences.

Decreased anti‐hepatitis C virus titer and associated factors in chronic hepatitis C patients after sustained virological response: A prospective study

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2012, Journal of gastroenterology and hepatology.

Aflatoxin exposure and hepatitis C virus in advanced liver disease in a hepatitis C virus endemic area in Taiwan.

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2007, The American journal of tropical medicine and hygiene.

Steatosis correlates with hepatic expression of death receptors and activation of nuclear factor‐κB in chronic hepatitis C

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2008, Liver international : official journal of the International Association for the Study of the Liver.

Well-Controlled Viremia Predicts the Outcome of Hepatocellular Carcinoma in Chronic Viral Hepatitis Patients Treated with Sorafenib

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2022, Cancers.

Identified cases of acute hepatitis C from computerized laboratory database: a hospital-based epidemiological and clinical study.

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2008, The Journal of infection.

Reappraisal of the roles of alpha-fetoprotein in hepatocellular carcinoma surveillance using large-scale nationwide database and hospital-based information.

Sheng-Nan Lu, Chien-Hung Chen, Yi‐Hsiang Huang, 2022, Journal of the Formosan Medical Association = Taiwan yi zhi.

Color Doppler Sonography of Bile Duct Tumor Thrombi in Hepatocellular Carcinoma

Sheng-Nan Lu, C. Changchien, Chuan‐Mo Lee, 2002, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

Significant association between serum Wisteria floribunda agglutinin-positive Mac-2-binding protein and prognosis of hepatocellular carcinoma after surgical treatment.

S. Chiu, Chi-Chih Wang, Yueh-Wei Liu, 2022, American journal of cancer research.

Predictors of Virological Suppression After Clinical Relapse in Patients Who Discontinued Entecavir or Tenofovir

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2021, Digestive Diseases and Sciences.

Liver stiffness measurement at complete virological response in hepatoma prediction for HBV‐related cirrhosis patient with potent antiviral agent

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2019, The Kaohsiung journal of medical sciences.

The change in liver stiffness, controlled attenuation parameter and fibrosis-4 index for chronic hepatitis C patients with direct-acting antivirals

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2019, PloS one.

Application of Ultrasound Liver Elastography to the Diagnosis and Monitoring of Liver Disease

Jing-Houng Wang, 2019, Journal of medical ultrasound.

A Mac-2 Binding Protein Glycosylation Isomer-Based Risk Model Predicts Hepatocellular Carcinoma in HBV-Related Cirrhotic Patients on Antiviral Therapy

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2022, Cancers.

Flash‐echo contrast sonography in the evaluation of response of small hepatocellular carcinoma to percutaneous ablation

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2006, Journal of clinical ultrasound : JCU.

Prevalence and clinical relevance of serum autoantibodies in patients with chronic hepatitis C.

Sheng-Nan Lu, Chien-Hung Chen, C. Chung, 2010, Chang Gung medical journal.

Chronic hepatitis C virus infection associated with dermatomyositis and hepatocellular carcinoma.

C. Changchien, Chuan‐Mo Lee, H. Eng, 2004, Chang Gung medical journal.

Down-regulation of tumor suppressor gene PTEN, overexpression of p53, plus high proliferating cell nuclear antigen index predict poor patient outcome of hepatocellular carcinoma after resection.

Sheng-Nan Lu, Chien-Hung Chen, M. Tai, 2007, Oncology reports.

Is delayed normalization of alanine aminotransferase a poor prognostic predictor in chronic hepatitis C patients treated with a combined interferon and ribavirin therapy?

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2002, Journal of gastroenterology and hepatology.

Hepatic Interferon Receptor Mrna Expression: Clinical Relevance and Its Relationship with Effectiveness of Interferon plus Ribavirin Therapy in Patients with Genotype 1B Hepatitis C Virus Infection

Sheng-Nan Lu, C. Changchien, Chuan‐Mo Lee, 2006, Antiviral therapy.

803 Lee.qxp

Sheng-Nan Lu, C. Changchien, Chuan‐Mo Lee, 2006 .

Study of hepatitis B (HB) vaccine non‐responsiveness among health care workers from an endemic area (Taiwan)

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2005, Liver international : official journal of the International Association for the Study of the Liver.

Low-dose nivolumab in advanced hepatocellular carcinoma

Jing-Houng Wang, Chao-Hung Hung, Yen-Yang Chen, 2022, BMC Cancer.

Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients.

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2007, Gastroenterology.

P21/WAF1 is an independent survival prognostic factor for patients with hepatocellular carcinoma after resection

Sheng-Nan Lu, Chien-Hung Chen, Chao-Long Chen, 2007, Liver international : official journal of the International Association for the Study of the Liver.

P 21 / WAF 1 is an independent survival prognostic factor for patients with hepatocellular carcinomaafter resection

Hung, Sheng-Nan Lu, Chien-Hung Chen, 2007 .

Dynamic noninvasive markers predict hepatocellular carcinoma in chronic hepatitis C patients without sustained virological response after interferon-based therapy

Sheng-Nan Lu, Chien-Hung Chen, C. Cho, 2017, Medicine.

Spontaneous clearance of hepatitis C virus in an interleukin 28B favorable genotype highly prevalent area

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2013, Hepatology.

Shear wave elastography for biliary hamartoma: An ancillary to diagnosis?

Jing-Houng Wang, 2019 .

Incidence and clinical outcome of icteric type hepatocellular carcinoma.

Sheng-Nan Lu, W. Chang, Jing-Houng Wang, 2003, Journal of gastroenterology and hepatology.

The ALBI grade predicts the prognosis of patients with advanced hepatocellular carcinoma received sorafenib

K. Rau, Sheng-Nan Lu, Chien-Hung Chen, 2017 .

A Sustained Virological Response to Interferon or Interferon/Ribavirin Reduces Hepatocellular Carcinoma and Improves Survival in Chronic Hepatitis C: A Nationwide, Multicentre Study in Taiwan

Sheng-Nan Lu, Y. Liaw, I. Sheen, 2006, Antiviral therapy.

Hepatitis C virus infection among teenagers in an endemic township in Taiwan: epidemiological and clinical follow-up studies

Sheng-Nan Lu, Ming‐Lung Yu, W. Chang, 2001, Epidemiology and Infection.

Tenofovir versus Entecavir in Treatment of Chronic Hepatitis B Virus with Severe Acute Exacerbation

Sheng-Nan Lu, Chien-Hung Chen, C.-H. Chen, 2015, Antimicrobial Agents and Chemotherapy.

A comparison of telbivudine and entecavir for chronic hepatitis B in real-world clinical practice.

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2012, The Journal of antimicrobial chemotherapy.

Combination therapy with interferon‐α and ribavirin in patients with dual hepatitis B and hepatitis C virus infection

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2005, Journal of gastroenterology and hepatology.

Comparisons of Viral Etiology and Outcomes of Hepatocellular Carcinoma Undergoing Liver Resection between Taiwan and Vietnam

Yueh-Wei Liu, Jing-Houng Wang, Chao-Hung Hung, 2022, Viruses.

Evolution of full-length HBV sequences in chronic hepatitis B patients with sequential lamivudine and adefovir dipivoxil resistance.

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2010, Journal of hepatology.

Serum hepatitis B surface antigen levels predict treatment response to nucleos(t)ide analogues.

Sheng-Nan Lu, Chien-Hung Chen, Y. Chiu, 2014, World journal of gastroenterology.

Characteristics of adefovir resistance in patients with or without lamivudine‐resistant hepatitis B virus treated with adefovir: a 4‐year experience

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2011, Liver international : official journal of the International Association for the Study of the Liver.

Community-Based Mass Ultrasonographic Screening of Hepatocellular Carcinoma among Thrombocytopenic Adults

T. Chen, Sheng-Nan Lu, Chien-Hung Chen, 2008, Cancer Epidemiology Biomarkers & Prevention.

Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in Taiwan.

J. Kao, Chun-Jen Liu, Chia-Chi Wang, 2022, Journal of hepatology.

Contrast‐Enhanced Ultrasonography in Hepatic Angiomyolipoma

Sheng-Nan Lu, C. Changchien, Jing-Houng Wang, 2005, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

Determinants of early mortality and benefits of lamivudine therapy in patients with hepatitis B virus‐related decompensated liver cirrhosis

Sheng-Nan Lu, C. Changchien, Chuan‐Mo Lee, 2005, Journal of viral hepatitis.

Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients

Chien-Jen Chen, Hwai I. Yang, Mei-Hsuan Lee, 2017, Scientific Reports.

Age, gender, and local geographic variations of viral etiology of hepatocellular carcinoma in a hyperendemic area for hepatitis B virus infection

Sheng-Nan Lu, Jui-Hsiang Tang, C. Yeh, 1999, Cancer.

Clinical implications of alpha-fetoprotein in chronic hepatitis C.

Sheng-Nan Lu, Chao-Hung Hung, Wei-Chen Tai, 2009, Journal of the Formosan Medical Association = Taiwan yi zhi.

Durability of lamivudine-induced HBeAg seroconversion for chronic hepatitis B patients with acute exacerbation.

Sheng-Nan Lu, C. Changchien, Chuan‐Mo Lee, 2002, Journal of hepatology.

Comparison of clinical outcome between patients continuing and discontinuing lamivudine therapy after biochemical breakthrough of YMDD mutants.

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2004, Journal of Hepatology.

Elevated body mass index is a risk factor associated with possible liver cirrhosis across different etiologies of chronic liver disease.

Chien-Hung Chen, Jing-Houng Wang, T. Hu, 2017, Journal of the Formosan Medical Association = Taiwan yi zhi.

Patients with interferon-induced HBeAg seroconversion have a higher risk of HBV reactivation and HBeAg seroreversion

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2014, Hepatology International.

Changes in serum hepatitis B e antigen (HBeAg) levels associated with the emergence of YMDD mutants in HBeAg non‐seroconverted patients during lamivudine therapy

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2007, Liver international : official journal of the International Association for the Study of the Liver.

CASE REPORT: Lamivudine Treatment for Recurrent Pancreatitis Associated with Reactivation of Chronic B Hepatitis

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2002, Digestive Diseases and Sciences.

Virological Response and Incidence of Adefovir Resistance in Lamivudine-Resistant Patients Treated with Adefovir Dipivoxil

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2005, Antiviral therapy.

Comparison of sequence changes of precore and core promoter regions in HBeAg-positive chronic hepatitis B patients with and without HBeAg clearance in lamivudine therapy.

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2006, Journal of hepatology.

HBV relapse rates in patients who discontinue tenofovir disoproxil fumarate with or without switching to tenofovir alafenamide.

Sheng-Nan Lu, Chien-Hung Chen, R. Chien, 2023, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Clinical significance and evolution of core promoter and precore mutations in HBeAg‐positive patients with HBV genotype B and C: a longitudinal study

Sheng-Nan Lu, Chao-Hung Hung, Sheng-Nan Lu, 2007, Liver international : official journal of the International Association for the Study of the Liver.

The Changes of Liver Stiffness and Its Associated Factors for Chronic Hepatitis B Patients with Entecavir Therapy

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2014, PloS one.

Hepatitis B virus infection in adolescents in a rural township--15 years subsequent to mass hepatitis B vaccination in Taiwan.

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2006, Vaccine.

Circulating microRNAs as biomarkers for diagnosis of early hepatocellular carcinoma associated with hepatitis B virus

Sheng-Nan Lu, Chien-Hung Chen, Y. Chiu, 2016, International journal of cancer.

Precore/core promoter mutations and hepatitis B virus genotype in hepatitis B and C dually infected patients treated with interferon-based therapy.

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2012, Antiviral research.

The role of hepatitis B surface antigen quantification in predicting HBsAg loss and HBV relapse after discontinuation of lamivudine treatment.

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2014, Journal of hepatology.

Title : The role of hepatitis B surface antigen quantification in predicting HBsAg loss and HBV relapse after discontinuation of lamivudine treatment Short title : HBsAg quantification predicting HBsAg loss

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2014 .

The Prevalence and Its Meaning of Anti-HBc Alone 15 Years Subsequent to Mass Hepatitis B Vaccination

Jing-Houng Wang, Tsung‐Ming Chen, 2003 .

Sustained HCV Clearance by Interferon-Based Therapy Reduces Hepatocellular Carcinoma in Hepatitis B and C Dually-Infected Patients

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2011, Antiviral therapy.

Entecavir vs. lamivudine in chronic hepatitis B patients with severe acute exacerbation and hepatic decompensation.

Sheng-Nan Lu, Chien-Hung Chen, R. Chien, 2014, Journal of hepatology.

Lower prevalence of hypercholesterolemia and hyperglyceridemia found in subjects with seropositivity for both Hepatitis B and C strains independently

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2010, Journal of gastroenterology and hepatology.

Incidence and Factors Associated With HBV Relapse After Cessation of Entecavir or Tenofovir in Patients With HBsAg Below 100 IU/mL.

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Combining the HBsAg decline and HBV DNA levels predicts clinical outcomes in patients with spontaneous HBeAg seroconversion

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2013, Hepatology International.

Combination and evolution of HBV mutant strains in the HBeAg-positive status predict clinical outcomes after HBeAg seroconversion

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2013, Hepatology International.

Association Between Level of Hepatitis B Surface Antigen and Relapse After Entecavir Therapy for Chronic Hepatitis B Virus Infection.

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Anemia associated with antiviral therapy in chronic hepatitis C: incidence, risk factors, and impact on treatment response

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2006, Liver international : official journal of the International Association for the Study of the Liver.

Acquirement and disappearance of HBsAg and anti‐HCV in an aged population: a follow‐up study in an endemic township

Kow-Tong Chen, Sheng-Nan Lu, Chien-Hung Chen, 2011, Liver international : official journal of the International Association for the Study of the Liver.

Hepatitis C core antigen highly correlated to HCV RNA

Sheng-Nan Lu, Jing-Houng Wang, Chao-Hung Hung, 2018, The Kaohsiung journal of medical sciences.

Did AFP‐L3 save ultrasonography in community screening?

Sheng-Nan Lu, Jing-Houng Wang, Chao-Hung Hung, 2018, The Kaohsiung journal of medical sciences.

Long-term outcomes of hepatitis B virus-related cirrhosis treated with nucleos(t)ide analogs.

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2017, Journal of the Formosan Medical Association = Taiwan yi zhi.

Combining age and HBsAg level predicts post‐treatment durability of nucleos(t)ide analogue‐induced HBeAg seroconversion

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2015, Journal of gastroenterology and hepatology.

PANCREAS, BILIARY TRACT, AND LIVER Association Between Level of Hepatitis B Surface Antigen and Relapse After Entecavir Therapy for Chronic Hepatitis B Virus Infection

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2015 .

Retreatment Efficacy and Renal Safety of Tenofovir Alafenamide, Entecavir, and Tenofovir Disoproxil Fumarate After Entecavir or Tenofovir Cessation

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2022, Digestive Diseases and Sciences.

Antiviral therapy after non‐surgical tumor ablation in patients with hepatocellular carcinoma associated with hepatitis C virus

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2005, Journal of gastroenterology and hepatology.

Comparison Stratagems of Post-Screening Management of Anti-HCV-Positive Community Residents: Simple Notification, Active Referral, or Accessible Medical Care

Sheng-Nan Lu, Jing-Houng Wang, Kuo-Chin Chang, 2015, PloS one.

A novel predictive score for hepatocellular carcinoma development in patients with chronic hepatitis C after sustained response to pegylated interferon and ribavirin combination therapy.

Sheng-Nan Lu, Chien-Hung Chen, M. Yen, 2012, The Journal of antimicrobial chemotherapy.

Increased oral lichen planus in a chronic hepatitis patient associated with elevated transaminase levels before and after interferon/ribavirin therapy

Sheng-Nan Lu, Jing-Houng Wang, Chao-Hung Hung, 2009 .

Three‐year efficacy and safety of tenofovir in nucleos(t)ide analog‐naïve and nucleos(t)ide analog‐experienced chronic hepatitis B patients

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2016, Journal of gastroenterology and hepatology.

APRI and FIB-4 in the evaluation of liver fibrosis in chronic hepatitis C patients stratified by AST level

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2018, PloS one.

Combining end-of-treatment HBsAg and baseline hepatitis B core-related antigen reduce HBV relapse rate after tenofovir cessation

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2021, Hepatology International.

ABNORMAL LIVER FUNCTION IN SCRUB TYPHUS

Sheng-Nan Lu, Ming‐Luen Hu, Keng-Liang Wu, 2005 .

Short report: Abnormal liver function in scrub typhus.

Sheng-Nan Lu, Ming‐Luen Hu, Keng-Liang Wu, 2005, The American journal of tropical medicine and hygiene.

Liver stiffness and insulin resistance in predicting recurrence for early stage hepatoma patients after curative resection

Sheng-Nan Lu, Chi-Chih Wang, Yueh-Wei Liu, 2021, Scientific Reports.

Liver Interleukin-8 Messenger RNA Expression and Interferon Sensitivity-Determining Region Mutations Relate to Treatment Response in Hepatitis C 1B

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2011, Antiviral therapy.

The Prognostic Value of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Patients with Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab

Chi-Chih Wang, Jing-Houng Wang, Chao-Hung Hung, 2022, Cancers.

Liver abscess complicating transcatheter arterial embolization: a rare but serious complication. A retrospective study after 3878 procedures

Sheng-Nan Lu, Yu-Fan Cheng, C. Changchien, 2004, European journal of gastroenterology & hepatology.

Predictive Effects of Inflammatory Scores in Patients with BCLC 0-A Hepatocellular Carcinoma after Hepatectomy

Sheng-Nan Lu, Chien-Hung Chen, Chi-Chih Wang, 2019, Journal of clinical medicine.

Clinical Impact of Gadoxetic Acid-Enhanced Magnetic Resonance Imaging on Hepatoma Management: A Prospective Study

Sheng-Nan Lu, Chien-Hung Chen, Chi-Chih Wang, 2016, Digestive Diseases and Sciences.

Different viral aetiology of hepatocellular carcinoma between two hepatitis B and C endemic townships in Taiwan

Chien-Jen Chen, S. You, M. Wu, 1997, Journal of gastroenterology and hepatology.

The impact of general anesthesia on radiofrequency ablation of hepatocellular carcinoma

Sheng-Nan Lu, Jing-Houng Wang, Chao-Hung Hung, 2014, The Kaohsiung journal of medical sciences.

Changing serum levels of quantitative hepatitis B surface antigen and hepatitis B virus DNA in hepatitis B virus surface antigen carriers: A follow‐up study of an elderly cohort

Sheng-Nan Lu, Jing-Houng Wang, Chao-Hung Hung, 2015, The Kaohsiung journal of medical sciences.

Community‐based cross‐sectional study: The association of lipids with hepatitis C seropositivity and diabetes mellitus

Sheng-Nan Lu, Chuan‐Mo Lee, Jing-Houng Wang, 2012, Journal of gastroenterology and hepatology.

Efficacy and Safety of Lenvatinib After Progression on First-line Atezolizumab Plus Bevacizumab Treatment in Advanced Hepatocellular Carcinoma Patients

Jing-Houng Wang, Chao-Hung Hung, Yen-Yang Chen, 2023, AntiCancer Research.

Incorporating albumin-bilirubin grade and up-to-seven criteria to predict outcomes of patients with intermediate stage hepatocellular carcinoma after transarterial (chemo)embolization.

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2021, Journal of the Formosan Medical Association = Taiwan yi zhi.

Overexpression of VEGF is associated with positive p53 immunostaining in hepatocellular carcinoma (HCC) and adverse outcome of HCC patients

Sheng-Nan Lu, Chien-Hung Chen, M. Tai, 2008, Journal of surgical oncology.

Changing prevalence of hepatitis C virus genotypes: Molecular epidemiology and clinical implications in the hepatitis C virus hyperendemic areas and a tertiary referral center in Taiwan

Jing-Houng Wang, J. Tsai, W. Chang, 2001, Journal of medical virology.

Clinical characteristics and distribution of genotypes of TT virus infection in a hepatitis C virus‐hyperendemic township of a hepatitis B virus‐endemic country (Taiwan)

Sheng-Nan Lu, W. Chang, Jing-Houng Wang, 2002, Journal of gastroenterology and hepatology.

Suppressor of cytokine signaling 1 expression in peripheral blood mononuclear cells of hepatitis C genotype 1 patients.

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2016, Journal of the Formosan Medical Association = Taiwan yi zhi.

Significance of Vitamin D Receptor Gene Polymorphisms for Risk of Hepatocellular Carcinoma in Chronic Hepatitis C

Sheng-Nan Lu, Chien-Hung Chen, Y. Chiu, 2014, Translational oncology.

Natural course of hepatic focal nodular hyperplasia: A long‐term follow‐up study with sonography

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2009, Journal of clinical ultrasound : JCU.

Correlation between ultrasonographic and pathologic diagnoses of hepatitis B and C virus-related cirrhosis

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2003, Journal of Gastroenterology.

The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma - Survival analysis of 3892 patients.

Sheng-Nan Lu, Chao-Long Chen, C. Changchien, 2008, European journal of cancer.

Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan.

M. Ho, Sheng-Nan Lu, Chun-Jen Liu, 2020, Journal of the Formosan Medical Association = Taiwan yi zhi.

A combination of the on‐treatment FIB‐4 and alpha‐foetoprotein predicts clinical outcomes in cirrhotic patients receiving entecavir

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2018, Liver international : official journal of the International Association for the Study of the Liver.

MicroRNA-122 as a predictor of HBsAg seroclearance in hepatitis B and C dual infected patients treated with interferon and ribavirin

Sheng-Nan Lu, Chien-Hung Chen, C. Cho, 2016, Scientific Reports.

Insulin resistance is associated with hepatocellular carcinoma in chronic hepatitis C infection.

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2010, World journal of gastroenterology.

Short Half-Life of Des-γ-Carboxy Prothrombin Is a Superior Factor for Early Prediction of Outcomes of Hepatocellular Carcinoma Treated with Radiofrequency Ablation

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2023, Diagnostics.

Favorable α‐fetoprotein decrease as a prognostic surrogate in patients with hepatocellular carcinoma after radiofrequency ablation

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2010, Journal of gastroenterology and hepatology.

The incidence of resistance-associated variants to NS5A in HCV subtypes 1a and 1b in Taiwan

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2020, Biomedical journal.

Active hepatocellular carcinoma is an independent risk factor of direct-acting antiviral treatment failure: A retrospective study with prospectively collected data

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2019, PloS one.

Clinical and novel application of FibroScan, FIB‐4 and aspartate aminotransferase‐to‐platelet ratio index in liver fibrosis evaluation in patients with hepatocellular carcinoma and their roles in oesophageal variceal prediction

Sheng-Nan Lu, Chi-Chih Wang, Jing-Houng Wang, 2020, International journal of clinical practice.

Hepatocellular Carcinoma associated with Extra-hepatic Primary Malignancy: its Secular change, Clinical Manifestations and Survival

Sheng-Nan Lu, Chi-Chih Wang, Yu-Fan Cheng, 2016, Scientific Reports.

Long-term outcome of liver complications in patients with chronic HBV/HCV co-infection after antiviral therapy: a real-world nationwide study on Taiwanese Chronic Hepatitis C Cohort (T-COACH)

J. Kao, Chun-Jen Liu, Chia-Chi Wang, 2021, Hepatology International.

Extrahepatic Malignancy Among Patients With Chronic Hepatitis C After Antiviral Therapy: A Real-World Nationwide Study on Taiwanese Chronic Hepatitis C Cohort (T-COACH).

J. Kao, Chun-Jen Liu, Chia-Chi Wang, 2020, The American journal of gastroenterology.

Incidence and clinical outcome of icteric type hepatocellular carcinoma

Sheng-Nan Lu, Ming‐Lung Yu, W. Chang, 2002, Journal of gastroenterology and hepatology.

Fine Needle Aspiration Cytodiagnosis of Liver Tumors

M. Tsou, Sheng-Nan Lu, H. Eng, 1998, Acta Cytologica.

Impact of pathological features of primary hepatocellular carcinoma on the outcomes of intrahepatic recurrence management: single center experience from Southern Taiwan.

Sheng-Nan Lu, Chi-Chih Wang, Jing-Houng Wang, 2016, HPB : the official journal of the International Hepato Pancreato Biliary Association.

How to improve the outcome in patients with AJCC stage I hepatocellular carcinoma.

Chi-Chih Wang, Yueh-Wei Liu, C. Yong, 2014, Anticancer research.

Neither Diabetes Mellitus nor Overweight Is a Risk Factor for Hepatocellular Carcinoma in a Dual HBV and HCV Endemic Area: Community Cross-Sectional and Case–Control Studies

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2010, The American Journal of Gastroenterology.

Incidence and predictors of retreatment in chronic hepatitis B patients after discontinuation of entecavir or tenofovir treatment

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2019, PloS one.

Diabetes mellitus, metabolic syndrome and obesity are not significant risk factors for hepatocellular carcinoma in an HBV‐ and HCV‐endemic area of Southern Taiwan

Sheng-Nan Lu, Jing-Houng Wang, Kuo-Chin Chang, 2013, The Kaohsiung journal of medical sciences.

Hepatocellular carcinoma surveillance and appropriate treatment options improve survival for patients with liver cirrhosis.

Sheng-Nan Lu, Chien-Hung Chen, Chao-Long Chen, 2010, European journal of cancer.

Neutrophil-to-Lymphocyte Ratio as a Predictor of Response to Peginterferon plus Ribavirin Therapy for Chronic Hepatitis C

Sheng-Nan Lu, Chien-Hung Chen, Y. Chiu, 2014, Disease markers.

Changing prevalence of anti-hepatitis A virus in adolescents in a rural township in Taiwan.

Sheng-Nan Lu, Jing-Houng Wang, Jung‐Ta Kao, 2010, Chang Gung medical journal.

Changing aetiology of liver dysfunction in the new generation of a hepatitis B and C‐endemic area: cross‐sectional studies on adolescents born in the first 10 years after universal hepatitis B vaccination

Sheng-Nan Lu, Chuan‐Mo Lee, Jing-Houng Wang, 2008, Liver international : official journal of the International Association for the Study of the Liver.

The role of hepatitis B virus core‐related antigen in predicting hepatitis B virus relapse after cessation of entecavir in hepatitis B e antigen‐negative patients

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2021, Journal of viral hepatitis.

Prediction model of hepatocellular carcinoma risk in Asian patients with chronic hepatitis B treated with entecavir

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2017, Oncotarget.

Associated Factors for Metabolic Syndrome in the Older Adults with Chronic Virus Hepatitis in the Community

Sheng-Nan Lu, Jing-Houng Wang, Kuo-Chin Chang, 2016, PloS one.

Long-Term Effect of Interferon Plus Ribavirin on Hepatitis B Surface Antigen Seroclearance in Patients Dually Infected with Hepatitis B and C Viruses

Ding‐Shinn Chen, Sheng-Nan Lu, J. Kao, 2011, PloS one.

Post-treatment HBsAg decline predicts high rate of HBsAg loss after stopping entecavir or tenofovir in HBeAg-negative patients without retreatment.

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2023, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

HBcrAg Predicts Hepatocellular Carcinoma Development in Chronic B Hepatitis Related Liver Cirrhosis Patients Undergoing Long-Term Effective Anti-Viral

Chien-Hung Chen, S. Chiu, Jing-Houng Wang, 2022, Viruses.

Comparison of incidence of hepatocellular carcinoma between chronic hepatitis B patients with cirrhosis treated with entecavir or tenofovir in Taiwan - a retrospective study.

Sheng-Nan Lu, C.-H. Chen, Jing-Houng Wang, 2020, American journal of cancer research.

Incidence and predictors of hepatocellular carcinoma beyond year 5 of entecavir therapy in chronic hepatitis B patients

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2020, Hepatology International.

Stratification of hepatocellular carcinoma risk through modified FIB‐4 index in chronic hepatitis B patients on entecavir therapy

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2018, Journal of gastroenterology and hepatology.

Role of hepatitis B surface antigen in hepatitis B virus relapse after entecavir or tenofovir prophylaxis in patients undergoing cancer chemotherapy

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2018, Journal of gastroenterology and hepatology.

The characteristics of patients with macrovascular invasion in hepatocellular carcinoma: when East meets West

Sheng-Nan Lu, Chi-Chih Wang, Yu-Fan Cheng, 2021, Langenbeck's Archives of Surgery.

Preoperative predictors of early recurrence after resection for hepatocellular carcinoma.

Sheng-Nan Lu, Chi-Chih Wang, Yueh-Wei Liu, 2021, American journal of surgery.

Validation of an alpha-fetoprotein model to predict recurrence after liver resection for hepatocellular carcinoma

Chi-Chih Wang, Yueh-Wei Liu, C. Yong, 2021, Updates in Surgery.

Characteristics and prognosis of patients with large well-differentiated hepatocellular carcinoma who have undergone resection.

Chien-Hung Chen, Chi-Chih Wang, Yueh-Wei Liu, 2021, American journal of surgery.

Liver resection in elderly patients with hepatocellular carcinoma: age does matter

Chi-Chih Wang, Yueh-Wei Liu, C. Yong, 2021, Updates in Surgery.

Six months as a cutoff time point to define early recurrence after liver resection of hepatocellular carcinoma based on post-recurrence survival

Chi-Chih Wang, Yueh-Wei Liu, C. Yong, 2020, Updates in Surgery.

Microscopic portal vein invasion is a powerful predictor of prognosis in patients with hepatocellular carcinoma who have undergone liver resection

Chi-Chih Wang, Yueh-Wei Liu, C. Yong, 2020, Journal of surgical oncology.

Liver resection of hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guideline recommendations: Results from a high‐volume liver surgery center in East Asia

Chien-Hung Chen, Chi-Chih Wang, Yueh-Wei Liu, 2020, Journal of surgical oncology.

Primary cultures of aspiration residual specimens predict outcomes of hepatocellular carcinoma patients receiving curative treatment

Jing-Houng Wang, M. Yeh, Chung‐Feng Huang, 2020, The Kaohsiung journal of medical sciences.

Pre-sarcopenia is the prognostic factor of overall survival in early-stage hepatoma patients undergoing radiofrequency ablation

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2020, Medicine.

Amino Acid Substitutions in the Core Region Associate with Insulin Resistance in Chronic Hepatitis C

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2013, Intervirology.

Liver Disease Screening and Hepatitis C Virus Elimination in Taiwan Rural Indigenous Townships: Village-By-Village Screening and Linking to Outreach Hepatology Care

Sheng-Nan Lu, Jing-Houng Wang, C. Shy, 2022, International journal of environmental research and public health.

Clinical utility of hepatitis C virus core antigen assay in the monitoring of direct-acting antivirals for chronic hepatitis C

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2020, PloS one.

Analysis of 6381 hepatocellular carcinoma patients in southern Taiwan: prognostic features, treatment outcome, and survival

Sheng-Nan Lu, Chao-Long Chen, Chi-Chih Wang, 2008, Journal of Gastroenterology.

[610] AN OPEN-LABEL, COMPARATIVE, MULTICENTER STUDY OF PEGINTERFERON a-2a PLUS RIBAVIRIN FOR CHRONIC HEPATITIS C/HEPATITIS B CO-INFECTION VERSUS CHRONIC HEPATITIS C MONOINFECTION: AN INTERIM REPORT

Ding‐Shinn Chen, Sheng-Nan Lu, J. Kao, 2007 .

Predicting outcomes for recurrent hepatocellular carcinoma within Milan criteria after complete radiofrequency ablation

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2020, PloS one.

The outcome of sorafenib monotherapy on hepatocellular carcinoma with portal vein tumor thrombosis

K. Rau, Sheng-Nan Lu, Chien-Hung Chen, 2018, Investigational New Drugs.

Endemic hepatitis B and C virus areas are associated with lower prevalence of hyperlipidemia: Ecological and cross‐sectional studies

Sheng-Nan Lu, Chuan‐Mo Lee, Jing-Houng Wang, 2017 .

Genetic predisposition of responsiveness to therapy for chronic hepatitis C.

Ding-Shinn Chen, Pei-Jer Chen, Chia-Yen Dai, 2006, Pharmacogenomics.

Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2021, Frontiers in Oncology.

Validation and modification of a proposed substaging system for patients with intermediate hepatocellular carcinoma

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2015, Journal of gastroenterology and hepatology.

Albumin‐Bilirubin grade predicts prognosis of HCC patients with sorafenib use

K. Rau, Sheng-Nan Lu, Chien-Hung Chen, 2017, Journal of gastroenterology and hepatology.

Ultrasonographic Quantification of Hepatic–Renal Echogenicity Difference in Hepatic Steatosis Diagnosis

Sheng-Nan Lu, Chao-Hung Hung, Hock-Liew Eng, 2013, Digestive Diseases and Sciences.

Peripheral blood toll-like receptor 4 correlates with rapid virological response to pegylated-interferon and ribavirin therapy in hepatitis C genotype 1 patients

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2016, BMC Gastroenterology.

Comparison of Therapeutic Response and Clinical Outcome between HCV Patients with Normal and Abnormal Alanine Transaminase Levels

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2016, PloS one.

Identifying hepatitis C virus: endemic areas and estimating the viral antibody prevalence based on the prevalence of ALT elevation.

T. Chen, Sheng-Nan Lu, Jing-Houng Wang, 2009, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Hepatocellular Carcinoma Surveillance at 4- vs. 12-Month Intervals for Patients With Chronic Viral Hepatitis: A Randomized Study in Community

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2013, The American Journal of Gastroenterology.

Impact of PNPLA3 and IFNL3 polymorphisms on hepatic steatosis in Asian patients with chronic hepatitis C

Sheng-Nan Lu, Chien-Hung Chen, C. Cho, 2017, PloS one.

The influence of direct-acting antivirals in hepatitis C virus related hepatocellular carcinoma after curative treatment

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2019, Investigational New Drugs.

Reversal of hypolipidemia in chronic hepatitis C patients after successful antiviral therapy.

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2011, Journal of the Formosan Medical Association = Taiwan yi zhi.

The Efficacy and Safety of Ramucirumab in Heavily Pretreated Advanced Hepatocellular Carcinoma

Jing-Houng Wang, Chao-Hung Hung, Yen-Yang Chen, 2023, AntiCancer Research.

Modifiable Prognostic Factors of Hepatocellular Carcinoma in Patients with Non-Surgical Treatment

Sheng-Nan Lu, Chien-Hung Chen, Yu-Fan Cheng, 2015, PloS one.

Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high‐risk for hepatocellular carcinoma

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2006, Cancer.

Combined resection and radiofrequency ablation versus transarterial embolization for intermediate-stage hepatocellular carcinoma: A propensity score matching study.

Sheng-Nan Lu, Chi-Chih Wang, Yueh-Wei Liu, 2017, Journal of the Formosan Medical Association = Taiwan yi zhi.

Sustained virological response and metabolic risk factors are associated with mortality in patients with chronic hepatitis C

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2019, PloS one.

Surgical resection improves the survival of selected hepatocellular carcinoma patients in Barcelona clinic liver cancer stage C.

Sheng-Nan Lu, Chi-Chih Wang, Jing-Houng Wang, 2013, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Minimally invasive surgery versus percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma: Results from a high-volume liver surgery center in East Asia.

Sheng-Nan Lu, Chien-Hung Chen, Chi-Chih Wang, 2022, Surgical oncology.

Higher rate of HBsAg loss after discontinuation of tenofovir than entecavir in patients with chronic hepatitis B.

Sheng-Nan Lu, C.-H. Chen, Jing-Houng Wang, 2023, Alimentary pharmacology & therapeutics.

The Incidence of Hepatitis B Surface Antigen Loss Between Hepatitis B E Antigen-Negative Noncirrhotic Patients Who Discontinued or Continued Entecavir Therapy

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2019, The Journal of infectious diseases.

Liver stiffness‐based score at sustained virologic response predicts liver‐related complications after eradication of hepatitis C virus

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2021, The Kaohsiung journal of medical sciences.

Liver stiffness‐based score in hepatoma risk assessment for chronic hepatitis C patients after successful antiviral therapy

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2016, Liver international : official journal of the International Association for the Study of the Liver.

Comparisons of noninvasive indices based on daily practice parameters for predicting liver cirrhosis in chronic hepatitis B and hepatitis C patients in hospital and community populations

Sheng-Nan Lu, Chuan‐Mo Lee, Jing-Houng Wang, 2013, The Kaohsiung journal of medical sciences.

Liver stiffness measurement as an alternative to fibrotic stage in risk assessment of hepatocellular carcinoma incidence for chronic hepatitis C patients

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2013, Liver international : official journal of the International Association for the Study of the Liver.

Liver stiffness measurement in the risk assessment of hepatocellular carcinoma for patients with chronic hepatitis

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2010, Hepatology international.

Liver stiffness decrease after effective antiviral therapy in patients with chronic hepatitis C: Longitudinal study using FibroScan

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2010, Journal of gastroenterology and hepatology.

Hepatitis C virus eradication decreases the risks of liver cirrhosis and cirrhosis‐related complications (Taiwanese chronic hepatitis C cohort)

J. Kao, Chun-Jen Liu, Chia-Chi Wang, 2021, Journal of gastroenterology and hepatology.

Community‐based screening for hepatocellular carcinoma in elderly residents in a hepatitis B‐ and C‐endemic area

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2011, Journal of gastroenterology and hepatology.

Corrigendum: Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2021, Frontiers in Oncology.

Impact of Steatosis on Long-Term Histological Outcome in Chronic Hepatitis C after Antiviral Therapy

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2005, Antiviral therapy.

Long‐term risk of end‐stage renal diseases with maintenance dialysis among chronic hepatitis C patients after antiviral therapy in Taiwan

J. Kao, Chun-Jen Liu, Chia-Chi Wang, 2021, Journal of gastroenterology and hepatology.

Using AST-platelet ratio index and fibrosis 4 index for detecting chronic hepatitis C in a large-scale community screening

Sheng-Nan Lu, Jing-Houng Wang, C. Hsiao, 2019, PloS one.

Small hepatic nodules (≤2 cm) in cirrhosis patients: characterization with contrast‐enhanced ultrasonography

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2006, Liver international : official journal of the International Association for the Study of the Liver.

Factors Predicting HBsAg Seroclearance and Alanine Transaminase Elevation in HBeAg-Negative Hepatitis B Virus-Infected Patients with Persistently Normal Liver Function

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2016, PloS one.

Kinetics in HBsAg after Stopping Entecavir or Tenofovir in Patients with Virological Relapse but Not Clinical Relapse

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2022, Viruses.

Successful Antiviral Therapy Reduces Risk of Schizophrenia Among Chronic Hepatitis C Patients: A Nationwide Real-World Taiwanese Cohort (T-COACH)

J. Kao, Chun-Jen Liu, Chia-Chi Wang, 2020, Open forum infectious diseases.

Adherence to the modified Barcelona Clinic Liver Cancer guidelines: Results from a high-volume liver surgery center in East Asias

Chien-Hung Chen, Chi-Chih Wang, Yu-Fan Cheng, 2021, PloS one.

Real world clinical practice in treating advanced hepatocellular carcinoma: When East meets West

Chien-Hung Chen, Yueh-Wei Liu, C. Yong, 2020, PloS one.

Hepatocellular carcinoma detected by regular surveillance: Does timely confirmation of diagnosis matter?

Sheng-Nan Lu, Jing-Houng Wang, Chao-Hung Hung, 2016, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Response to Giannini et al.

Sheng-Nan Lu, Jing-Houng Wang, 2013, The American Journal of Gastroenterology.

Incidence and associated risk factors of hepatocellular carcinoma in a dural hepatitis B and C virus endemic area: A surveillance study

Sheng-Nan Lu, Jing-Houng Wang, Chao-Hung Hung, 2011, The Kaohsiung journal of medical sciences.

On-Treatment Changes in FIB-4 and 1-Year FIB-4 Values Help Identify Patients with Chronic Hepatitis B Receiving Entecavir Therapy Who Have the Lowest Risk of Hepatocellular Carcinoma

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2020, Cancers.

Hepatitis delta virus and GBV-C infection in two neighboring hepatitis B virus and hepatitis C virus-endemic villages in Taiwan.

Sheng-Nan Lu, Jing-Houng Wang, Jui-chin Chiang, 2010, Chang Gung medical journal.

Flash‐echo gray‐scale imaging in the subtraction mode for assessing perfusion of small hepatocellular carcinoma

Sheng-Nan Lu, C. Changchien, Chuan‐Mo Lee, 2003, Journal of clinical ultrasound : JCU.

Validation of the 7th Edition TNM Staging System for Hepatocellular Carcinoma: An Analysis of 8,828 Patients in a Single Medical Center

Sheng-Nan Lu, Chi-Chih Wang, Yu-Fan Cheng, 2013, Digestive Diseases and Sciences.

MO5-4 Potential roles of gut microbiome in patients with hepatocellular carcinoma treated with immune checkpoint inhibitors

Wei-Hsiang Lee, Chun-Ying Wu, Bang-Bin Chen, 2022, Annals of Oncology.

Radiofrequency ablation of small hepatocellular carcinoma with intravenous pegylated liposomal doxorubicin

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2011, Hepatology international.

Hepatitis C virus core antigen is cost-effective in community-based screening of active hepatitis C infection in Taiwan.

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2019, Journal of the Formosan Medical Association = Taiwan yi zhi.

Hepatic steatosis with hepatitis B virus/hepatitis C virus dual infection

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2010, Hepatology.

Prediction of viremia for cases of hepatitis C virus (HCV) infection using a third-generation anti-HCV enzyme immunoassay test.

Sheng-Nan Lu, C. Changchien, Chuan‐Mo Lee, 2005, Hepato-gastroenterology.

Is the Cancer of the Liver Italian Program system an adequate weighting for survival of hepatocellular carcinoma? Evaluation of intrascore prognostic value among 36 subgroups

Sheng-Nan Lu, Chao-Long Chen, Chi-Chih Wang, 2009, Liver international : official journal of the International Association for the Study of the Liver.

Primary Hepatocellular Carcinoma in Ectopic Liver and Later Metastasis to Mother Liver: A Case Report and Review of the Literature

Chuan‐Mo Lee, Jing-Houng Wang, T. Hu, 2008 .

Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan.

M. Ho, Y. Ni, Chien-Hung Chen, 2017, Journal of the Formosan Medical Association = Taiwan yi zhi.

Community-based screening by Anti-HCV reflex HCV Ag test and accessible post-screening care toward elimination of hepatitis C in two hyperendemic townships.

Sheng-Nan Lu, Jing-Houng Wang, Yu‐Chen Lin, 2022, Journal of the Formosan Medical Association = Taiwan yi zhi.

Characteristics and etiologies of hepatocellular carcinoma in patients without cirrhosis: When East meets West

Chi-Chih Wang, Yu-Fan Cheng, Jing-Houng Wang, 2021, PloS one.

Changing prevalence of hepatitis C virus genotypes: Molecular epidemiology and clinical implications in the hepatitis C virus hyperendemic areas and a tertiary referral center in Taiwan

Ming‐Lung Yu, Jing-Houng Wang, J. Tsai, 2001, Journal of medical virology.

Hepatic Clostridium Perfringens Abscess Formation after Radiofrequency Ablation Therapy for Hepatocellular Carcinoma: Report of a Rare Case

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2021, Case Reports in Oncology.

Sheng-Nan Lu, Chuan‐Mo Lee, Jing-Houng Wang, 2008, Liver international : official journal of the International Association for the Study of the Liver.

Impact of diabetes mellitus on incidence of hepatocellular carcinoma in chronic hepatitis C patients treated with interferon‐based antiviral therapy

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2011, International journal of cancer.

Characteristics of adefovir resistance in patients with or without lamivudine‐resistant hepatitis B virus treated with adefovir: a 4‐year experience

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2011, Liver international : official journal of the International Association for the Study of the Liver.

LIVER CIRRHOSIS AND HEPATOCELLULAR CARCINOMA Incidence and clinical outcome of icteric type hepatocellular carcinoma

Sheng-Nan Lu, W. Chang, Jing-Houng Wang, 2002 .

Impact of Genomic Alterations on the Clinical Outcome of Patients With Hepatitis B-related Hepatocellular Carcinoma Receiving Curative Surgery: A Retrospective Cohort Study

S. Pang, Jing-Houng Wang, E. Huang, 2023, AntiCancer Research.